Stern RH - Search Results

1

Cimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reduction.

Stern RH, Gibson DM, Whitfield LR. Stern RH, et al. Eur J Clin Pharmacol. 1998 Feb;53(6):475-8. doi: 10.1007/s002280050409. Eur J Clin Pharmacol. 1998. PMID: 9551707 Clinical Trial.

2

Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion.

Boyd RA, Stern RH, Stewart BH, Wu X, Reyner EL, Zegarac EA, Randinitis EJ, Whitfield L. Boyd RA, et al. Among authors: stern rh. J Clin Pharmacol. 2000 Jan;40(1):91-8. doi: 10.1177/00912700022008612. J Clin Pharmacol. 2000. PMID: 10631627 Clinical Trial.

3

Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase.

Whitfield LR, Stern RH, Sedman AJ, Abel R, Gibson DM. Whitfield LR, et al. Among authors: stern rh. Eur J Drug Metab Pharmacokinet. 2000 Apr-Jun;25(2):97-101. doi: 10.1007/BF03190074. Eur J Drug Metab Pharmacokinet. 2000. PMID: 11112089 Clinical Trial.

4

Atorvastatin does not alter the anticoagulant activity of warfarin.

Stern R, Abel R, Gibson GL, Besserer J. Stern R, et al. J Clin Pharmacol. 1997 Nov;37(11):1062-4. doi: 10.1002/j.1552-4604.1997.tb04288.x. J Clin Pharmacol. 1997. PMID: 9506000

5

Rate of low-density lipoprotein cholesterol and apolipoprotein B changes on initiation and discontinuation of atorvastatin treatment.

Stern RH, Abel RB. Stern RH, et al. J Clin Pharmacol. 1997 Apr;37(4):291-6. doi: 10.1002/j.1552-4604.1997.tb04305.x. J Clin Pharmacol. 1997. PMID: 9115054 Clinical Trial.

6

Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatin.

Stern RH, Yang BB, Horton M, Moore S, Abel RB, Olson SC. Stern RH, et al. J Clin Pharmacol. 1997 Sep;37(9):816-9. doi: 10.1002/j.1552-4604.1997.tb05629.x. J Clin Pharmacol. 1997. PMID: 9549635

7

Atorvastatin does not produce a clinically significant effect on the pharmacokinetics of terfenadine.

Stern RH, Smithers JA, Olson SC. Stern RH, et al. J Clin Pharmacol. 1998 Aug;38(8):753-7. doi: 10.1002/j.1552-4604.1998.tb04816.x. J Clin Pharmacol. 1998. PMID: 9725552 Clinical Trial.

8

Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor.

Stern RH, Yang BB, Hounslow NJ, MacMahon M, Abel RB, Olson SC. Stern RH, et al. J Clin Pharmacol. 2000 Jun;40(6):616-23. J Clin Pharmacol. 2000. PMID: 10868312

9

Erythromycin coadministration increases plasma atorvastatin concentrations.

Siedlik PH, Olson SC, Yang BB, Stern RH. Siedlik PH, et al. Among authors: stern rh. J Clin Pharmacol. 1999 May;39(5):501-4. J Clin Pharmacol. 1999. PMID: 10234598

10

Effect of troglitazone on steady-state pharmacokinetics of digoxin.

Loi CM, Knowlton PW, Stern R, Randinitis EJ, Vassos AB, Koup JR, Sedman AJ. Loi CM, et al. J Clin Pharmacol. 1998 Feb;38(2):178-83. doi: 10.1002/j.1552-4604.1998.tb04408.x. J Clin Pharmacol. 1998. PMID: 9549650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters